Cargando…
Ischemia-Modified Albumin as a Marker of Acute Coronary Syndrome: The Case for Revising the Concept of “N-Terminal Modification” to “Fatty Acid Occupation” of Albumin
Ischemia-modified albumin (IMA) is assumed “N-terminal modified” albumin which is generated immediately following myocardial ischemia. The diagnosis of IMA is based on reduced cobalt binding affinity to albumin which is attributed mainly to incapability of cobalt to bind at albumin's modified N...
Autores principales: | Oran, Ismail, Oran, Bulent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357514/ https://www.ncbi.nlm.nih.gov/pubmed/28356609 http://dx.doi.org/10.1155/2017/5692583 |
Ejemplares similares
-
The Role of Ischemia-modified Albumin and Ischemia-Modified Albumin to Albumin Ratios in Patients with Alopecia Areata
por: Tanacan, Efsun, et al.
Publicado: (2023) -
Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding
por: Coverdale, James P.C., et al.
Publicado: (2018) -
Ischemia-modified albumin must be evaluated as an oxidative stress marker together with albumin and bilirubin in individuals with acute appendicitis
por: Reddy, Varikasuvu Seshadri, et al.
Publicado: (2015) -
Correlation between ischemia-modified albumin level and coronary collateral circulation
por: Chen, Xin, et al.
Publicado: (2020) -
Ischemia-Modified Albumin: Origins and Clinical Implications
por: Shevtsova, Alla, et al.
Publicado: (2021)